1338227-35-2

Upstream product

• 120-14-9 3,4-dimethoxy-benzaldehyde 
• 123-54-6 acetylacetone 

Downstream Products

• 1338227-30-7 (1E,4Z,6E)-1-(3,4-dimethoxyphenyl)-7-(4-(2-fluoroethoxy)-3-methoxyphenyl)-5-hydroxy-hepta-1,4,6-trien-3-one 
• 1338227-31-8 (1E,4Z,6E)-1-(3,4-dimethoxyphenyl)-7-(4-(3-fluoropropoxy)-3-methoxyphenyl)-5-hydroxy-hepta-1,4,6-trien-3-one 
• 1338227-34-1 (1E,4Z,6E)-1-(3,4-dimethoxyphenyl)-7-(4-(2-(2-fluoroethoxy)ethoxy)-3-methoxyphenyl)-5-hydroxy-hepta-1,4,6-trien-3-one 

Relevant academic research and scientific papers

Synthesis and evaluation of 1-(4-[18F]fluoroethyl)-7-(4′- methyl)curcumin with improved brain permeability for β-amyloid plaque imaging

Alzheimer's disease is characterized by the accumulation of β-amyloid (Aβ) plaques and neurofibrillary tangles (NFTs) in the brain. We previously developed [18F]fluoropropylcurcumin ([18F]FP-curcumin), which demonstrated excellent bi